Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment.
van den Berg SA, Uniken Venema SM, Mulder MJHL, Treurniet KM, Samuels N, Lingsma HF, Goldhoorn RB, Jansen IGH, Coutinho JM, Roozenbeek B, Dippel DWJ, Roos YBWEM, van der Worp HB, Nederkoorn PJ; MR CLEAN Registry Investigators†. van den Berg SA, et al. Stroke. 2020 Nov;51(11):3205-3214. doi: 10.1161/STROKEAHA.120.029907. Epub 2020 Oct 12. Stroke. 2020. PMID: 33040702 Free PMC article.
Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design.
Chalos V, A van de Graaf R, Roozenbeek B, C G M van Es A, M den Hertog H, Staals J, van Dijk L, F M Jenniskens S, J van Oostenbrugge R, H van Zwam W, B W E M Roos Y, B L M Majoie C, F Lingsma H, van der Lugt A, W J Dippel D; MR CLEAN-MED investigators. Chalos V, et al. Trials. 2020 Jul 14;21(1):644. doi: 10.1186/s13063-020-04514-9. Trials. 2020. PMID: 32665035 Free PMC article.
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial.
Frey BM, Boutitie F, Cheng B, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Ford I, Galinovic I, Königsberg A, Puig J, Roy P, Wouters A, Magnus T, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G; WAKE-UP investigators. Frey BM, et al. Neurol Res Pract. 2020 Nov 20;2:40. doi: 10.1186/s42466-020-00087-9. eCollection 2020. Neurol Res Pract. 2020. PMID: 33324940 Free PMC article.
Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy.
van den Berg SA, Uniken Venema SM, LeCouffe NE, Postma AA, Lycklama À Nijeholt GJ, Rinkel LA, Treurniet KM, Kappelhof M, Bruggeman AE, van Kranendonk KR, Majoie CB, Dippel DW, van der Worp HB, Coutinho JM, Nederkoorn PJ, Roos YB. van den Berg SA, et al. Eur Stroke J. 2023 Sep;8(3):647-654. doi: 10.1177/23969873231173274. Epub 2023 May 11. Eur Stroke J. 2023. PMID: 37641554 Free PMC article. Clinical Trial.
Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment.
Rinkel LA, Treurniet KM, Nieboer D, Kappelhof M, LeCouffe NE, Bruggeman AAE, van Zwam WH, Lycklama À Nijeholt GJ, Ghariq E, Uyttenboogaart M, Dippel DWJ, Roos YBWEM, Coutinho JM, Majoie CBLM, Emmer BJ; MR CLEAN-NO IV Investigators. Rinkel LA, et al. Stroke. 2022 Nov;53(11):3278-3288. doi: 10.1161/STROKEAHA.121.038390. Epub 2022 Jul 25. Stroke. 2022. PMID: 35876018 Clinical Trial.
Neurological Deficits in Stroke Patients that May Impede the Capacity to Provide Informed Consent for Endovascular Treatment Trials.
Janssen PM, Chalos V, van den Berg SA, Kompanje EJO, Nederkoorn PJ, van der Worp BH, van Zwam WH, Dippel DWJ; MR CLEAN Registry Investigators. Janssen PM, et al. J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104447. doi: 10.1016/j.jstrokecerebrovasdis.2019.104447. Epub 2019 Oct 14. J Stroke Cerebrovasc Dis. 2019. PMID: 31624035
Time Since Stroke Onset, Quantitative Collateral Score, and Functional Outcome After Endovascular Treatment for Acute Ischemic Stroke.
Uniken Venema SM, Wolff L, van den Berg SA, Reinink H, Luijten SPR, Lingsma HF, Marquering HA, Boers AMM, Bot J, Hammer S, Nederkoorn PJ, Roos YBWEM, Majoie CBLM, Dankbaar JW, van der Lugt A, van der Worp HB; MR CLEAN Registry Investigators. Uniken Venema SM, et al. Among authors: van der lugt a, van den berg sa, van der worp hb. Neurology. 2022 Oct 11;99(15):e1609-e1618. doi: 10.1212/WNL.0000000000200968. Epub 2022 Aug 2. Neurology. 2022. PMID: 35918164 Free PMC article. Clinical Trial.
Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
Huijberts I, Pinckaers FME, Olthuis SGH, van Kuijk SMJ, Postma AA, Boogaarts HD, Roos YBWEM, Majoie CBLM, van der Lugt A, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ; MR CLEAN-LATE investigators. Huijberts I, et al. Lancet Neurol. 2024 Sep;23(9):893-900. doi: 10.1016/S1474-4422(24)00228-X. Epub 2024 Jun 20. Lancet Neurol. 2024. PMID: 38909624 Clinical Trial.
413 results